Invader® Cystic Fibrosis (CF) genotyping analyte-specific reagents from Third Wave Technologies enable CLIA-certified laboratories to develop individual assays for each of the 25 CF genetic mutations recommended for screening by the American College of Medical Genetics (ACMG) and the American College of Obstetricians and Gynecologists (ACOG). The Invader CF genotyping analyte-specific reagents provide users with access to a range of products to meet the unique needs of CF testing. Invader technology offers maximum throughput flexibility, allowing for the simple automation of high-throughput testing.

Third Wave Technologies
(312) 853-7000; www.twt.com